25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

EZB (Enzo) Stock Analysis
Buy, Hold or Sell?

Let's analyze Enzo together

I guess you are interested in Enzo Biochem Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Enzo’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Enzo’s Price Targets

I'm going to help you getting a better view of Enzo Biochem Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Enzo Biochem Inc

I send you an email if I find something interesting about Enzo Biochem Inc.

1. Quick Overview

1.1. Quick analysis of Enzo (30 sec.)










1.2. What can you expect buying and holding a share of Enzo? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€0.71
Expected worth in 1 year
€0.29
How sure are you?
29.4%

+ What do you gain per year?

Total Gains per Share
€-0.42
Return On Investment
-107.7%

For what price can you sell your share?

Current Price per Share
€0.39
Expected price per share
€0.388 - €0.388
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Enzo (5 min.)




Live pricePrice per Share (EOD)
€0.39
Intrinsic Value Per Share
€-5.16 - €-6.00
Total Value Per Share
€-4.45 - €-5.29

2.2. Growth of Enzo (5 min.)




Is Enzo growing?

Current yearPrevious yearGrowGrow %
How rich?$43.3m$73.1m-$24.6m-51.0%

How much money is Enzo making?

Current yearPrevious yearGrowGrow %
Making money-$5.2m$11.1m-$16.4m-312.2%
Net Profit Margin-74.2%-112.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Enzo (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Enzo?

Welcome investor! Enzo's management wants to use your money to grow the business. In return you get a share of Enzo.

First you should know what it really means to hold a share of Enzo. And how you can make/lose money.

Speculation

The Price per Share of Enzo is €0.388. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Enzo.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Enzo, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €0.71. Based on the TTM, the Book Value Change Per Share is €-0.10 per quarter. Based on the YOY, the Book Value Change Per Share is €0.20 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Enzo.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 β‚¬% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share
Usd Eps-0.05-13.7%-0.10-25.9%-0.09-23.8%-0.14-35.3%-0.09-22.5%-0.07-18.1%
Usd Book Value Change Per Share-0.06-15.8%-0.12-31.6%0.2461.7%-0.03-7.7%-0.02-4.7%0.026.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.06-15.8%-0.12-31.6%0.2461.7%-0.03-7.7%-0.02-4.7%0.026.3%
Usd Price Per Share0.46-0.89-1.39-1.53-2.06-3.54-
Price to Earnings Ratio-2.14--3.44--4.21--3.48-1.79--19.68-
Price-to-Total Gains Ratio-7.41--13.02--18.14--14.40--7.75-98.17-
Price to Book Ratio0.55-0.94-0.99-1.90-2.08-2.68-
Price-to-Total Gains Ratio-7.41--13.02--18.14--14.40--7.75-98.17-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.4552016
Number of shares2196
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.12-0.02
Usd Total Gains Per Share-0.12-0.02
Gains per Quarter (2196 shares)-269.25-39.79
Gains per Year (2196 shares)-1,076.98-159.18
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1077-10870-159-169
20-2154-21640-318-328
30-3231-32410-478-487
40-4308-43180-637-646
50-5385-53950-796-805
60-6462-64720-955-964
70-7539-75490-1114-1123
80-8616-86260-1273-1282
90-9693-97030-1433-1441
100-10770-107800-1592-1600

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%4.016.00.020.0%6.028.00.017.6%6.028.00.017.6%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%5.015.00.025.0%10.024.00.029.4%10.024.00.029.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.034.00.0%0.00.034.00.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%5.015.00.025.0%10.024.00.029.4%10.024.00.029.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Enzo Biochem Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.052-0.105+100%0.204-126%-0.026-51%-0.015-70%0.021-352%
Book Value Per Share--0.7060.788-10%1.191-41%0.865-18%0.932-24%1.095-36%
Current Ratio--2.8382.813+1%3.053-7%2.450+16%2.450+16%3.218-12%
Debt To Asset Ratio--0.3170.335-5%0.301+5%0.396-20%0.409-23%0.338-6%
Debt To Equity Ratio--0.4640.505-8%0.435+7%0.796-42%0.779-40%0.596-22%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--3183704.75218695954.858-83%34786006.900-91%39667106.953-92%58567933.632-95%129072873.630-98%
Eps---0.045-0.086+89%-0.079+73%-0.117+157%-0.074+64%-0.060+32%
Ev To Sales Ratio--0.1460.801-82%0.862-83%0.911-84%0.916-84%1.673-91%
Free Cash Flow Per Share---0.059-0.067+13%-0.176+200%-0.124+111%-0.091+56%-0.091+55%
Free Cash Flow To Equity Per Share---0.059-0.104+75%-0.180+204%-0.133+125%-0.098+65%-0.091+54%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---6.001----------
Intrinsic Value_10Y_min---5.161----------
Intrinsic Value_1Y_max---0.511----------
Intrinsic Value_1Y_min---0.502----------
Intrinsic Value_3Y_max---1.603----------
Intrinsic Value_3Y_min---1.529----------
Intrinsic Value_5Y_max---2.780----------
Intrinsic Value_5Y_min---2.574----------
Market Cap20312886.4000%20332287.95239643045.558-49%62103509.000-67%68424738.853-70%91994117.712-78%157838941.783-87%
Net Profit Margin---0.436-0.742+70%-1.126+158%-0.842+93%-0.517+19%-0.353-19%
Operating Margin----0%-0.1750%-0.2850%-0.1920%-0.1930%
Operating Ratio--2.1411.996+7%2.1430%2.213-3%1.939+10%1.821+18%
Pb Ratio0.5500%0.5500.942-42%0.994-45%1.904-71%2.081-74%2.681-80%
Pe Ratio-2.1370%-2.137-3.439+61%-4.208+97%-3.482+63%1.790-219%-19.679+821%
Price Per Share0.3880%0.3880.757-49%1.186-67%1.307-70%1.757-78%3.015-87%
Price To Free Cash Flow Ratio-1.6540%-1.654-5.154+212%-2.395+45%-3.847+133%-5.022+204%-3.406+106%
Price To Total Gains Ratio-7.4120%-7.412-13.022+76%-18.142+145%-14.403+94%-7.752+5%98.167-108%
Quick Ratio--0.2530.206+23%0.162+56%0.249+2%0.548-54%0.600-58%
Return On Assets---0.044-0.067+52%0.086-151%-0.041-6%-0.027-38%-0.026-41%
Return On Equity---0.064-0.102+58%0.139-146%-0.116+80%-0.074+15%-0.059-9%
Total Gains Per Share---0.052-0.105+100%0.204-126%-0.026-51%-0.015-70%0.021-352%
Usd Book Value--43399548.44148447728.553-10%73138359.484-41%53129978.943-18%57219591.522-24%67233751.756-35%
Usd Book Value Change Per Share---0.061-0.123+100%0.239-126%-0.030-51%-0.018-70%0.024-352%
Usd Book Value Per Share--0.8280.925-10%1.397-41%1.015-18%1.093-24%1.284-36%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--3735122.41521934094.239-83%40810943.295-91%46537449.877-92%68711899.737-95%151428295.343-98%
Usd Eps---0.053-0.101+89%-0.092+73%-0.137+157%-0.087+64%-0.070+32%
Usd Free Cash Flow---3606128.662-4087145.824+13%-10800385.344+200%-7593520.927+111%-5615350.349+56%-3611893.574+0%
Usd Free Cash Flow Per Share---0.069-0.078+13%-0.206+200%-0.145+111%-0.107+56%-0.107+55%
Usd Free Cash Flow To Equity Per Share---0.070-0.122+75%-0.212+204%-0.157+125%-0.115+65%-0.107+54%
Usd Market Cap23831078.3240%23853840.22546509221.049-49%72859836.759-67%80275903.622-70%107927498.899-78%185176646.500-87%
Usd Price Per Share0.4550%0.4550.888-49%1.392-67%1.533-70%2.061-78%3.537-87%
Usd Profit---2790099.547-5270688.051+89%11183649.018-125%-1827065.187-35%-1360148.528-51%-1801799.580-35%
Usd Revenue--6402228.4236868995.077-7%1180292.111+442%8600390.184-26%16362883.807-61%19151948.023-67%
Usd Total Gains Per Share---0.061-0.123+100%0.239-126%-0.030-51%-0.018-70%0.024-352%
 EOD+0 -2MRQTTM+22 -13YOY+14 -213Y+17 -185Y+16 -1910Y+11 -24

3.3 Fundamental Score

Let's check the fundamental score of Enzo Biochem Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.137
Price to Book Ratio (EOD)Between0-10.550
Net Profit Margin (MRQ)Greater than0-0.436
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.253
Current Ratio (MRQ)Greater than12.838
Debt to Asset Ratio (MRQ)Less than10.317
Debt to Equity Ratio (MRQ)Less than10.464
Return on Equity (MRQ)Greater than0.15-0.064
Return on Assets (MRQ)Greater than0.05-0.044
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Enzo Biochem Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.229
Ma 20Greater thanMa 500.388
Ma 50Greater thanMa 1000.388
Ma 100Greater thanMa 2000.367
OpenGreater thanClose0.388
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Enzo Biochem Inc

Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York.

Fundamental data was last updated by Penke on 2025-08-19 11:12:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Enzo earns for each €1 of revenue.

  • Above 10% is considered healthy but always compareΒ Enzo to theΒ Diagnostics & Research industry mean.
  • A Net Profit Margin of -43.6%Β means thatΒ €-0.44 for each €1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Enzo Biochem Inc:

  • The MRQ is -43.6%. The company is making a huge loss. -2
  • The TTM is -74.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-43.6%TTM-74.2%+30.6%
TTM-74.2%YOY-112.6%+38.4%
TTM-74.2%5Y-51.7%-22.4%
5Y-51.7%10Y-35.3%-16.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-43.6%-0.9%-42.7%
TTM-74.2%-5.6%-68.6%
YOY-112.6%-3.6%-109.0%
3Y-84.2%-7.0%-77.2%
5Y-51.7%-1.1%-50.6%
10Y-35.3%-1.0%-34.3%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Enzo is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Enzo to theΒ Diagnostics & Research industry mean.
  • -4.4% Return on Assets means thatΒ Enzo generatedΒ €-0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Enzo Biochem Inc:

  • The MRQ is -4.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -6.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.4%TTM-6.7%+2.3%
TTM-6.7%YOY8.6%-15.3%
TTM-6.7%5Y-2.7%-4.0%
5Y-2.7%10Y-2.6%-0.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.4%-0.4%-4.0%
TTM-6.7%-1.0%-5.7%
YOY8.6%-0.9%+9.5%
3Y-4.1%-1.3%-2.8%
5Y-2.7%0.3%-3.0%
10Y-2.6%0.3%-2.9%
4.3.1.3. Return on Equity

Shows how efficient Enzo is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Enzo to theΒ Diagnostics & Research industry mean.
  • -6.4% Return on Equity means Enzo generated €-0.06Β for eachΒ €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Enzo Biochem Inc:

  • The MRQ is -6.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -10.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.4%TTM-10.2%+3.7%
TTM-10.2%YOY13.9%-24.1%
TTM-10.2%5Y-7.4%-2.8%
5Y-7.4%10Y-5.9%-1.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.4%0.2%-6.6%
TTM-10.2%-0.9%-9.3%
YOY13.9%-0.2%+14.1%
3Y-11.6%-1.9%-9.7%
5Y-7.4%-0.6%-6.8%
10Y-5.9%-0.9%-5.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Enzo Biochem Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Enzo is operatingΒ .

  • Measures how much profit Enzo makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Enzo to theΒ Diagnostics & Research industry mean.
  • An Operating Margin of 0.0%Β means the company generated €0.00 Β for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Enzo Biochem Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-17.5%+17.5%
TTM-5Y-19.2%+19.2%
5Y-19.2%10Y-19.3%+0.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.0%+16.0%
TTM--12.4%+12.4%
YOY-17.5%-8.8%-8.7%
3Y-28.5%0.8%-29.3%
5Y-19.2%3.1%-22.3%
10Y-19.3%2.9%-22.2%
4.3.2.2. Operating Ratio

Measures how efficient Enzo is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Diagnostics & Research industry mean).
  • An Operation Ratio of 2.14 means that the operating costs are €2.14 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Enzo Biochem Inc:

  • The MRQ is 2.141. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.996. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.141TTM1.996+0.145
TTM1.996YOY2.143-0.147
TTM1.9965Y1.939+0.057
5Y1.93910Y1.821+0.118
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1411.329+0.812
TTM1.9961.328+0.668
YOY2.1431.238+0.905
3Y2.2131.260+0.953
5Y1.9391.212+0.727
10Y1.8211.148+0.673
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Enzo Biochem Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Enzo is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Diagnostics & Research industry mean).
  • A Current Ratio of 2.84Β means the company has €2.84 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Enzo Biochem Inc:

  • The MRQ is 2.838. The company is able to pay all its short-term debts. +1
  • The TTM is 2.813. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.838TTM2.813+0.025
TTM2.813YOY3.053-0.239
TTM2.8135Y2.450+0.363
5Y2.45010Y3.218-0.768
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8382.012+0.826
TTM2.8132.140+0.673
YOY3.0532.336+0.717
3Y2.4502.421+0.029
5Y2.4502.689-0.239
10Y3.2183.137+0.081
4.4.3.2. Quick Ratio

Measures if Enzo is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Enzo to theΒ Diagnostics & Research industry mean.
  • A Quick Ratio of 0.25Β means the company can pay off €0.25 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Enzo Biochem Inc:

  • The MRQ is 0.253. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.206. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.253TTM0.206+0.047
TTM0.206YOY0.162+0.044
TTM0.2065Y0.548-0.341
5Y0.54810Y0.600-0.052
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2531.215-0.962
TTM0.2061.229-1.023
YOY0.1621.431-1.269
3Y0.2491.763-1.514
5Y0.5481.899-1.351
10Y0.6002.242-1.642
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Enzo Biochem Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of EnzoΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Enzo to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.32Β means that Enzo assets areΒ financed with 31.7% credit (debt) and the remaining percentage (100% - 31.7%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Enzo Biochem Inc:

  • The MRQ is 0.317. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.335. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.317TTM0.335-0.018
TTM0.335YOY0.301+0.034
TTM0.3355Y0.409-0.074
5Y0.40910Y0.338+0.071
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3170.399-0.082
TTM0.3350.426-0.091
YOY0.3010.387-0.086
3Y0.3960.389+0.007
5Y0.4090.413-0.004
10Y0.3380.444-0.106
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Enzo is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Enzo to theΒ Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 46.4% means that company has €0.46 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Enzo Biochem Inc:

  • The MRQ is 0.464. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.505. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.464TTM0.505-0.041
TTM0.505YOY0.435+0.070
TTM0.5055Y0.779-0.274
5Y0.77910Y0.596+0.183
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4640.611-0.147
TTM0.5050.598-0.093
YOY0.4350.615-0.180
3Y0.7960.645+0.151
5Y0.7790.636+0.143
10Y0.5960.660-0.064
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every €1 in earnings Enzo generates.

  • Above 15 is considered overpriced butΒ always compareΒ Enzo to theΒ Diagnostics & Research industry mean.
  • A PE ratio of -2.14 means the investor is paying €-2.14Β for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Enzo Biochem Inc:

  • The EOD is -2.137. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.137. Based on the earnings, the company is expensive. -2
  • The TTM is -3.439. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.137MRQ-2.1370.000
MRQ-2.137TTM-3.439+1.302
TTM-3.439YOY-4.208+0.769
TTM-3.4395Y1.790-5.230
5Y1.79010Y-19.679+21.469
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-2.137-0.244-1.893
MRQ-2.137-0.367-1.770
TTM-3.439-0.404-3.035
YOY-4.208-0.189-4.019
3Y-3.4820.993-4.475
5Y1.7906.415-4.625
10Y-19.6798.149-27.828
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Enzo Biochem Inc:

  • The EOD is -1.654. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.654. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.154. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.654MRQ-1.6540.000
MRQ-1.654TTM-5.154+3.501
TTM-5.154YOY-2.395-2.760
TTM-5.1545Y-5.022-0.133
5Y-5.02210Y-3.406-1.615
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-1.6543.310-4.964
MRQ-1.6543.242-4.896
TTM-5.154-0.244-4.910
YOY-2.395-0.230-2.165
3Y-3.8470.164-4.011
5Y-5.022-0.203-4.819
10Y-3.406-0.197-3.209
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Enzo is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 0.55 means the investor is paying €0.55Β for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Enzo Biochem Inc:

  • The EOD is 0.550. Based on the equity, the company is cheap. +2
  • The MRQ is 0.550. Based on the equity, the company is cheap. +2
  • The TTM is 0.942. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.550MRQ0.5500.000
MRQ0.550TTM0.942-0.393
TTM0.942YOY0.994-0.051
TTM0.9425Y2.081-1.139
5Y2.08110Y2.681-0.600
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD0.5502.218-1.668
MRQ0.5502.044-1.494
TTM0.9422.121-1.179
YOY0.9942.272-1.278
3Y1.9042.484-0.580
5Y2.0813.313-1.232
10Y2.6814.369-1.688
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-04-30. Currency in USD. All numbers in thousands.

Summary
Total Assets63,516
Total Liabilities20,118
Total Stockholder Equity43,398
 As reported
Total Liabilities 20,118
Total Stockholder Equity+ 43,398
Total Assets = 63,516

Assets

Total Assets63,516
Total Current Assets48,278
Long-term Assets15,238
Total Current Assets
Cash And Cash Equivalents 36,693
Net Receivables 4,309
Inventory 5,714
Other Current Assets 1,562
Total Current Assets  (as reported)48,278
Total Current Assets  (calculated)48,278
+/-0
Long-term Assets
Property Plant Equipment 14,852
Long-term Assets Other 386
Long-term Assets  (as reported)15,238
Long-term Assets  (calculated)15,238
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities17,011
Long-term Liabilities3,107
Total Stockholder Equity43,398
Total Current Liabilities
Short Long Term Debt 73
Accounts payable 1,395
Other Current Liabilities 10,293
Total Current Liabilities  (as reported)17,011
Total Current Liabilities  (calculated)11,761
+/- 5,250
Long-term Liabilities
Long term Debt 129
Capital Lease Obligations Min Short Term Debt2,801
Long-term Liabilities  (as reported)3,107
Long-term Liabilities  (calculated)2,930
+/- 177
Total Stockholder Equity
Total Stockholder Equity (as reported)43,398
Total Stockholder Equity (calculated)0
+/- 43,398
Other
Capital Stock523
Common Stock Shares Outstanding 52,403
Net Invested Capital 43,600
Net Working Capital 31,267
Property Plant and Equipment Gross 14,852



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-04-302025-01-312024-10-312024-07-312024-04-302024-01-312023-10-312023-07-312023-04-302023-01-312022-10-312022-07-312022-04-302022-01-312021-10-312021-07-312021-04-302021-01-312020-10-312020-07-312020-04-302020-01-312019-10-312019-07-312019-04-302019-01-312018-10-312018-07-312018-04-302018-01-312017-10-312017-07-312017-04-302017-01-31
> Total Assets 
106,391
106,577
107,665
109,256
108,325
105,451
101,660
94,183
89,120
111,000
106,640
125,236
116,782
116,348
112,538
113,503
112,031
113,623
113,691
108,139
108,822
103,904
95,857
85,199
76,452
72,061
121,880
106,308
99,077
93,469
85,764
75,291
67,510
63,516
63,51667,51075,29185,76493,46999,077106,308121,88072,06176,45285,19995,857103,904108,822108,139113,691113,623112,031113,503112,538116,348116,782125,236106,640111,00089,12094,183101,660105,451108,325109,256107,665106,577106,391
   > Total Current Assets 
86,879
87,462
89,084
90,983
89,539
86,416
83,200
75,508
63,640
85,723
81,453
77,294
71,100
72,300
68,765
70,302
69,883
71,341
70,582
65,912
66,710
62,299
54,354
44,579
36,381
31,999
98,456
88,012
80,920
75,736
70,031
59,661
52,217
48,278
48,27852,21759,66170,03175,73680,92088,01298,45631,99936,38144,57954,35462,29966,71065,91270,58271,34169,88370,30268,76572,30071,10077,29481,45385,72363,64075,50883,20086,41689,53990,98389,08487,46286,879
       Cash And Cash Equivalents 
62,427
62,627
64,167
66,849
64,468
62,556
60,041
52,777
41,978
64,052
60,146
56,893
51,502
54,407
47,865
45,914
44,536
45,021
13,524
6,356
4,159
31,130
21,603
12,135
5,054
2,632
82,373
69,207
60,241
57,156
52,371
47,735
40,297
36,693
36,69340,29747,73552,37157,15660,24169,20782,3732,6325,05412,13521,60331,1304,1596,35613,52445,02144,53645,91447,86554,40751,50256,89360,14664,05241,97852,77760,04162,55664,46866,84964,16762,62762,427
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
29,932
29,978
29,810
29,480
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000029,48029,81029,97829,93200000000000000000
       Net Receivables 
15,355
15,805
15,180
14,443
14,977
14,407
13,147
12,836
11,665
11,441
10,738
9,877
8,912
6,817
9,141
12,051
12,095
11,475
10,198
11,332
15,316
11,761
11,516
11,515
10,866
9,636
4,808
4,181
5,116
3,935
3,988
3,842
4,245
4,309
4,3094,2453,8423,9883,9355,1164,1814,8089,63610,86611,51511,51611,76115,31611,33210,19811,47512,09512,0519,1416,8178,9129,87710,73811,44111,66512,83613,14714,40714,97714,44315,18015,80515,355
       Inventory 
7,115
7,170
7,047
7,210
7,481
7,278
7,278
7,588
7,514
7,595
7,842
7,568
7,502
8,018
7,784
8,185
9,258
11,007
12,652
13,957
13,851
14,934
15,411
15,787
15,723
15,289
7,939
7,595
7,800
7,324
6,832
6,391
5,987
5,714
5,7145,9876,3916,8327,3247,8007,5957,93915,28915,72315,78715,41114,93413,85113,95712,65211,0079,2588,1857,7848,0187,5027,5687,8427,5957,5147,5887,2787,2787,4817,2107,0477,1707,115
       Other Current Assets 
1,982
1,860
2,690
2,481
2,613
2,175
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,738
4,442
1,000
1,000
2,763
2,321
1,840
1,693
1,688
1,562
1,5621,6881,6931,8402,3212,7631,0001,0004,4424,7380000000000000000002,1752,6132,4812,6901,8601,982
   > Long-term Assets 
0
0
0
0
0
0
0
0
2,715
25,277
25,187
47,942
45,682
44,048
43,773
43,201
42,148
42,282
43,109
42,227
42,112
41,605
41,503
40,620
40,071
40,062
23,424
18,296
18,157
17,733
15,733
15,630
15,293
15,238
15,23815,29315,63015,73317,73318,15718,29623,42440,06240,07140,62041,50341,60542,11242,22743,10942,28242,14843,20143,77344,04845,68247,94225,18725,2772,71500000000
       Property Plant Equipment 
8,168
8,093
7,901
7,837
7,945
7,953
7,636
7,503
13,925
14,244
14,254
37,146
35,581
34,107
34,398
33,822
32,922
33,036
33,605
33,212
32,934
32,507
32,433
31,559
30,994
30,963
16,712
16,480
16,024
15,597
15,203
15,149
14,866
14,852
14,85214,86615,14915,20315,59716,02416,48016,71230,96330,99431,55932,43332,50732,93433,21233,60533,03632,92233,82234,39834,10735,58137,14614,25414,24413,9257,5037,6367,9537,9457,8377,9018,0938,168
       Goodwill 
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
7,452
0
0
0
0
0
0
0
0
000000007,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,452
       Intangible Assets 
3,560
3,244
2,895
2,647
2,449
2,149
1,886
1,625
1,388
1,128
1,032
892
752
588
538
460
393
315
244
171
100
29
0
0
0
0
0
0
0
0
0
0
0
0
000000000000291001712443153934605385887528921,0321,1281,3881,6251,8862,1492,4492,6472,8953,2443,560
       Long-term Assets Other 
0
0
0
0
0
0
0
0
25,480
2,453
2,449
2,452
1,897
1,901
1,385
1,467
1,381
1,479
1,808
1,392
1,626
1,617
1,618
1,609
1,625
1,647
6,712
1,816
2,133
2,136
530
481
427
386
3864274815302,1362,1331,8166,7121,6471,6251,6091,6181,6171,6261,3921,8081,4791,3811,4671,3851,9011,8972,4522,4492,45325,48000000000
> Total Liabilities 
18,663
18,015
18,793
20,074
20,366
19,072
20,539
18,513
21,623
20,001
20,612
46,908
45,922
54,018
54,157
54,485
50,242
48,656
45,105
41,379
43,696
41,717
41,395
40,209
43,622
53,133
43,418
32,033
28,302
24,438
29,652
27,633
20,894
20,118
20,11820,89427,63329,65224,43828,30232,03343,41853,13343,62240,20941,39541,71743,69641,37945,10548,65650,24254,48554,15754,01845,92246,90820,61220,00121,62318,51320,53919,07220,36620,07418,79318,01518,663
   > Total Current Liabilities 
17,565
16,958
17,810
19,541
19,871
18,668
20,186
18,193
16,596
15,272
16,009
22,999
23,200
31,870
32,801
33,608
29,949
29,214
26,076
23,106
26,148
24,702
24,550
24,253
32,201
42,152
39,989
28,842
25,283
21,663
24,794
23,397
17,176
17,011
17,01117,17623,39724,79421,66325,28328,84239,98942,15232,20124,25324,55024,70226,14823,10626,07629,21429,94933,60832,80131,87023,20022,99916,00915,27216,59618,19320,18618,66819,87119,54117,81016,95817,565
       Short-term Debt 
0
1,047
904
89
60
37
23
0
0
0
136
138
149
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000149138136000233760899041,0470
       Short Long Term Debt 
0
1,047
904
89
60
37
23
0
0
0
136
138
149
0
7,144
7,000
7,000
7,000
152
0
0
0
229
0
3,684
7,175
2,589
2,917
3,300
3,684
76
76
73
73
737376763,6843,3002,9172,5897,1753,68402290001527,0007,0007,0007,1440149138136000233760899041,0470
       Accounts payable 
16,706
16,161
10,350
9,558
9,564
8,250
9,516
7,155
7,773
6,423
7,256
8,630
8,185
8,523
8,503
7,842
4,432
6,014
8,123
5,929
6,860
7,664
8,508
8,109
13,189
13,645
3,575
1,962
1,318
1,520
1,376
1,269
672
1,395
1,3956721,2691,3761,5201,3181,9623,57513,64513,1898,1098,5087,6646,8605,9298,1236,0144,4327,8428,5038,5238,1858,6307,2566,4237,7737,1559,5168,2509,5649,55810,35016,16116,706
       Other Current Liabilities 
859
797
409
402
409
413
420
190
264
392
391
138
149
2,526
2,526
2,526
2,526
2,414
2,675
2,099
681
157
0
312
235
75
21,102
13,001
13,363
10,874
17,402
10,798
11,014
10,293
10,29311,01410,79817,40210,87413,36313,00121,1027523531201576812,0992,6752,4142,5262,5262,5262,526149138391392264190420413409402409797859
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
5,027
4,729
4,603
23,909
22,722
22,148
21,356
20,877
20,293
19,442
19,029
18,273
17,548
17,015
16,845
15,956
11,421
10,981
3,429
3,191
3,019
2,775
4,858
4,236
3,718
3,107
3,1073,7184,2364,8582,7753,0193,1913,42910,98111,42115,95616,84517,01517,54818,27319,02919,44220,29320,87721,35622,14822,72223,9094,6034,7295,02700000000
       Capital Lease Obligations Min Short Term Debt
0
-1,047
-904
-89
-60
-37
-23
0
0
0
288
24,448
23,194
22,121
21,161
20,396
19,545
18,566
18,168
17,402
16,545
16,090
16,281
15,506
14,635
14,497
4,140
3,892
3,647
3,394
3,244
3,036
2,919
2,801
2,8012,9193,0363,2443,3943,6473,8924,14014,49714,63515,50616,28116,09016,54517,40218,16818,56619,54520,39621,16122,12123,19424,448288000-23-37-60-89-904-1,0470
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
563
494
0
352
280
223
31
173
155
0
5
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000055015517331223280352049456300000000
> Total Stockholder Equity
87,728
88,562
88,872
89,182
87,959
86,379
81,121
75,670
67,497
90,999
86,028
78,328
70,860
62,330
58,381
59,018
61,789
64,967
68,586
66,760
65,126
62,187
54,462
44,990
32,830
18,928
78,462
74,275
70,775
69,031
56,112
47,658
46,616
43,398
43,39846,61647,65856,11269,03170,77574,27578,46218,92832,83044,99054,46262,18765,12666,76068,58664,96761,78959,01858,38162,33070,86078,32886,02890,99967,49775,67081,12186,37987,95989,18288,87288,56287,728
   Common Stock
463
464
465
470
471
472
472
472
472
476
476
476
476
479
479
479
482
485
485
485
485
487
487
487
487
496
499
504
0
0
0
0
0
0
000000504499496487487487487485485485485482479479479476476476476472472472472471470465464463
   Retained Earnings Total Equity0000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000
   Capital Surplus 0000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000
   Other Stockholders Equity 
2,437
2,321
2,013
2,096
1,518
1,847
2,100
2,370
2,172
2,378
2,580
2,309
2,226
2,510
1,681
1,852
1,270
1,268
1,352
1,629
1,971
2,882
3,151
3,884
2,529
2,157
1,878
2,746
0
0
0
0
0
0
0000002,7461,8782,1572,5293,8843,1512,8821,9711,6291,3521,2681,2701,8521,6812,5102,2262,3092,5802,3782,1722,3702,1001,8471,5182,0962,0132,3212,437



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-07-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue31,907
Cost of Revenue-17,275
Gross Profit14,63214,632
 
Operating Income (+$)
Gross Profit14,632
Operating Expense-44,272
Operating Income-12,365-29,640
 
Operating Expense (+$)
Research Development2,642
Selling General Administrative24,355
Selling And Marketing Expenses-
Operating Expense44,27226,997
 
Net Interest Income (+$)
Interest Income3,538
Interest Expense-197
Other Finance Cost-0
Net Interest Income3,341
 
Pretax Income (+$)
Operating Income-12,365
Net Interest Income3,341
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-9,817-11,572
EBIT - interestExpense = -197
-26,078
-25,881
Interest Expense197
Earnings Before Interest and Taxes (EBIT)--9,620
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-9,817
Tax Provision-0
Net Income From Continuing Ops-9,817-9,817
Net Income-26,078
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-793-3,341
 

Technical Analysis of Enzo
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Enzo. The general trend of Enzo is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Enzo's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Enzo Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Enzo Biochem Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.388 < 0.388 < 0.388.

The bearish price targets are: 0.388 > 0.388 > 0.388.

Know someone who trades $EZB? Share this with them.πŸ‘‡

Enzo Biochem Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Enzo Biochem Inc. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Enzo Biochem Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Enzo Biochem Inc. The current macd is 0.00011752.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Enzo price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Enzo. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Enzo price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Enzo Biochem Inc Daily Moving Average Convergence/Divergence (MACD) ChartEnzo Biochem Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Enzo Biochem Inc. The current adx is 2.57328701.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Enzo shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Enzo Biochem Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Enzo Biochem Inc. The current sar is 0.39871191.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Enzo Biochem Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Enzo Biochem Inc. The current rsi is 55.23. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
Enzo Biochem Inc Daily Relative Strength Index (RSI) ChartEnzo Biochem Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Enzo Biochem Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Enzo price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Enzo Biochem Inc Daily Stochastic Oscillator ChartEnzo Biochem Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Enzo Biochem Inc. The current cci is 66.67.

Enzo Biochem Inc Daily Commodity Channel Index (CCI) ChartEnzo Biochem Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Enzo Biochem Inc. The current cmo is 19.31.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Enzo Biochem Inc Daily Chande Momentum Oscillator (CMO) ChartEnzo Biochem Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Enzo Biochem Inc. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Enzo Biochem Inc Daily Williams %R ChartEnzo Biochem Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Enzo Biochem Inc.

Enzo Biochem Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Enzo Biochem Inc. The current atr is 0.00011399.

Enzo Biochem Inc Daily Average True Range (ATR) ChartEnzo Biochem Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Enzo Biochem Inc. The current obv is 11,620.

Enzo Biochem Inc Daily On-Balance Volume (OBV) ChartEnzo Biochem Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Enzo Biochem Inc. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Enzo Biochem Inc Daily Money Flow Index (MFI) ChartEnzo Biochem Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Enzo Biochem Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-01 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-02 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-07 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-08 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-10 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-11 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-15 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-17 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-25 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-02 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-05 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-09 00:00:00MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-12 00:00:00MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-13 00:00:00MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-15 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-16 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-20 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-22 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-28 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside

6.3. Candlestick Patterns

Enzo Biochem Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Enzo Biochem Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.229
Ma 20Greater thanMa 500.388
Ma 50Greater thanMa 1000.388
Ma 100Greater thanMa 2000.367
OpenGreater thanClose0.388
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Enzo with someone you think should read this too:
  • Are you bullish or bearish on Enzo? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Enzo? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Enzo Biochem Inc

I send you an email if I find something interesting about Enzo Biochem Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Enzo Biochem Inc.

Receive notifications about Enzo Biochem Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.